Featured Press Releases

VTAMA® (tapinarof) Cream, 1%, Demonstrates Early and Consistent Efficacy in Children Aged 2+ with Atopic Dermatitis, According to New Data

VTAMA® (tapinarof) Cream, 1%, Demonstrates Early and Consistent Efficacy in Children Aged 2+ with Atopic Dermatitis, According to New Data

MalarVx licenses HDT Bio

MalarVx licenses HDT Bio's repRNA/LION™ technology to develop a groundbreaking malaria vaccine

  • 20 Jan 2025

MalarVx, Inc., a clinical-stage vaccine company, is proud to announce a license to HDT Bio's...

Ratio Therapeutics partners with Macrocyclics for exclusive production and global distribution of its Macropa™ radiopharmaceutical platform

Ratio Therapeutics partners with Macrocyclics for exclusive production and global distribution of its Macropa™ radiopharmaceutical platform

Novel Compound AC102 Makes Constant Ear Noise Disappear in Preclinical Model: Tinnitus Research

Novel Compound AC102 Makes Constant Ear Noise Disappear in Preclinical Model: Tinnitus Research

Incyte announces FDA approval of Jakafi XR for treating myelofibrosis, polycythemia vera, and graft-versus-host disease

Incyte announces FDA approval of Jakafi XR for treating myelofibrosis, polycythemia vera, and graft-versus-host disease

AddiVance Offers a Drug-Free Option for Daily Focus, Attention, and Cognitive Support for Families

AddiVance Offers a Drug-Free Option for Daily Focus, Attention, and Cognitive Support for Families

Dr. Oregonin Completes U.S. FDA Registration for OLTIS DENTAL-X, Unveiling Oral Care Innovation Rooted in Trans-Pacific Alder Research

Dr. Oregonin Completes U.S. FDA Registration for OLTIS DENTAL-X, Unveiling Oral Care Innovation Rooted in Trans-Pacific Alder Research

  • Dr. Oregonin Inc
  • 06 Oct 2026
SHARx Warns: The Pharmacy Budget Trap — Why Discounts Alone Cannot Control Total Spending

SHARx Warns: The Pharmacy Budget Trap — Why Discounts Alone Cannot Control Total Spending

  • SHARx
  • 05 Oct 2026
Aptar Pharma Launched Premia™ Precision, Establishing a New Quality Standard for Demanding Injectable Therapies

Aptar Pharma Launched Premia™ Precision, Establishing a New Quality Standard for Demanding Injectable Therapies

  • Aptar Pharma
  • 05 Oct 2026
Hovione to Bring Next-Generation Continuous Tableting to the U.S. with the World’s First ConsiGma® CDC Flex Commissioning

Hovione to Bring Next-Generation Continuous Tableting to the U.S. with the World’s First ConsiGma® CDC Flex Commissioning

  • Hovione
  • 04 Oct 2026
CaseBioscience® Joins Team Awarded Up to $7.3 Million by ARPA-H to Advance Ambient Preservation of Cell Therapies

CaseBioscience® Joins Team Awarded Up to $7.3 Million by ARPA-H to Advance Ambient Preservation of Cell Therapies

  • CaseBioscience
  • 02 Oct 2026
Ensera Launched Alliance Network with SHL Medical, Stevanato Group, Ypsomed, Argonaut, and American Injectables.

Ensera Launched Alliance Network with SHL Medical, Stevanato Group, Ypsomed, Argonaut, and American Injectables.

  • Ensera
  • 02 Oct 2026

Most Popular
October   2026
M T W T F S S
      1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31  

User Area

Discover

Engage with Us

© Pharmaceutical Era — A product of HISSM. All Rights Reserved.